Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

245
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
245
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

576
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
576
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

104
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
104
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

31
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
31
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

14
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
14
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

11
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
11

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Implementing portable, real-time 16S rRNA sequencing in the healthcare sector enhances antimicrobial stewardship.

EBioMedicine·2026
Same author

Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy: A Randomized, Triple-Masked, Placebo-Controlled Clinical Trial.

Anesthesiology·2026
Same author

BPI26-018: Integrated Specialty Prostate Cancer Care: Outcomes From a Collaborative Clinic Model at UC San Diego Moores Cancer Center.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Cervical spinal injury associated with patient positioning during percutaneous nephrolithotomy.

Urology case reports·2026
Same author

Healthcare resource utilization comparing single-use ureteroscopes with real-time intrarenal pressure monitoring to other single-use ureteroscopes.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same author

BPI26-018: Integrated Specialty Prostate Cancer Care: Outcomes From a Collaborative Clinic Model at UC San Diego Moores Cancer Center.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Editorial Commentary.

Urology practice·2026
Same journal

Reply by authors.

Urology practice·2026
Same journal

The Impact of Patient-Provider Relationships on Prostate Cancer Screening: A Cross-Sectional Analysis of the All of Us Research Program.

Urology practice·2026
Same journal

Adjuvant Radiation Therapy Versus Initial Observation for Patients After Prostatectomy with Adverse Pathology: Have Findings from 3 Randomized Clinical Trials Influenced Clinical Practice?

Urology practice·2026
Same journal

National Patterns and Predictors of Perioperative Intravesical Chemotherapy Use Following Nephroureterectomy for Upper Tract Urothelial Carcinoma.

Urology practice·2026
Same journal

Patient Trust and Medical Mistrust Toward Overactive Bladder Therapies: General Consumer Awareness and Perceptions.

Urology practice·2026
查看所有相关文章

相关实验视频

Updated: Jul 19, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.5K

流体玻尿酸治疗:当前的实践

Sarah Tarplin1, Benjamin Larson2, Michael Byrne2

  • 1Stevan Streem Center for Endourology & Stone Disease, Cleveland, Ohio.

Urology practice
|August 10, 2023
PubMed
概括
此摘要是机器生成的。

静脉注射液体球体通常用于结石,但大多数患者不需要它们. 这种做法仍然存在,尽管有证据表明对急性结肠治疗没有好处.

关键词:
应急服务的紧急服务.医院 医院 医院 医院骨髓灰质炎是一种神经病.脏结肠发作 脏结肠发作尿路甲基石质症是什么意思

更多相关视频

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.2K
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

1.2K

相关实验视频

Last Updated: Jul 19, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.5K
Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.2K
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

1.2K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學.
  • 紧急医疗 紧急医疗
  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科

背景情况:

  • 静脉注射液体球体是治疗尿病和急性结肠的标准急诊室实践.
  • 从历史上看,液体的管理旨在促进尿管流动,但证据显示没有好处.

研究的目的:

  • 评估目前在急诊室为尿病患者进行静脉注射液体玻尿剂的实践.
  • 根据已确定的低血压的标准来确定是否进行液体玻尿酸注射.

主要方法:

  • 用CT扫描对肺结核病 (ICD-9 592.0) 的急诊室访问进行了回顾性分析.
  • 评估静脉注射液体博卢斯发生率和与低血压指标的相关性 (BUN与肌素比率>20,尿液特异性重量>1.030).

主要成果:

  • 60.2%的结石病患者接受了静脉注射的液体.
  • 79.12%接受液体注射的患者不符合体积耗尽的标准.
  • 接受液体注射剂的患者和没有接受液体注射剂的患者之间的低血压率没有显著差异.

结论:

  • 在急诊室内为尿病注射静脉液体是常见的,通常没有明显的低血压迹象.
  • 目前的做法可能是由历史习惯驱动的,而不是急性结肠治疗的基于证据的指南.